Second malignant neoplasm (SMN) in a cohort of early stage cancer survivors (ESCS) followed at Instituto Oncológico Henry Moore (IOHM) in the last 15 years
Autor: | Edgardo G. J. Rivarola, Dario Niewiadomski, Ernesto Gil Deza, Flavio Tognelli, Felipe G. Gercovich, Claudia Lorena Acuna, Eduardo L. Morgenfeld, N. Gercovich |
---|---|
Rok vydání: | 2016 |
Předmět: | |
Zdroj: | Journal of Clinical Oncology. 34:e13057-e13057 |
ISSN: | 1527-7755 0732-183X |
DOI: | 10.1200/jco.2016.34.15_suppl.e13057 |
Popis: | e13057Background: The prolonged survival achieved when tumors are treated at early stages allows the diagnosis of a SMN in many patients during the follow up period.The following study aims to present the incidence of secondary tumors in a cohort of ESCS patients (Pt) followed at IOHM. Methods: A search of the IOHM database was carried out, looking for Pt that had been registered between 1/12/2000 and 1/6/2015 with early stage (0-I-II-III) tumors and had been followed for more than six months. Those with a SMN were identified. In all of these, the following was studied: Dx, detection (screening vs symptomatic), presentation (synchronic vs metachronic) and stage. Results: It was possible to find 12038 ESCS that met selection criteria. Population characteristics: Median age at Dx of primary tumor: 58 years (r 18-98y). Sex: male 4689 Pt (39%) / female 7335 Pt (61%). Median follow up was 40 months (r 6-183m). The table below shows primary tumors and most frequent SMN. In 476/556 Pt (86%), SMN was metachronic ... |
Databáze: | OpenAIRE |
Externí odkaz: |